世界の急性虚血性脳卒中治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Ischemic Stroke Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0063 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性虚血性脳卒中治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤）、用途別市場規模（病院、外来手術センター、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性虚血性脳卒中治療の市場動向 ・企業の競争状況、市場シェア ・急性虚血性脳卒中治療の種類別市場規模（血栓溶解療法、降圧療法、抗血小板療法、抗凝固剤） ・急性虚血性脳卒中治療の用途別市場規模（病院、外来手術センター、診断センター） ・急性虚血性脳卒中治療の北米市場規模2016-2027（アメリカ、カナダ） ・急性虚血性脳卒中治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性虚血性脳卒中治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性虚血性脳卒中治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性虚血性脳卒中治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Boehringer Ingelheim、Roche、Sanofi、Biogen、Daiichi Sankyo、Pfizer） ・結論

AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
Technavio’s analysts forecast the global acute ischemic stroke therapeutics market to grow at a CAGR of 2.11% during the period 2017-2025.

Market Analysis and Insights: Global Acute Ischemic Stroke Therapeutics Market
The global Acute Ischemic Stroke Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of 2.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Ischemic Stroke Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Ischemic Stroke Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Ischemic Stroke Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Ischemic Stroke Therapeutics market.

Global Acute Ischemic Stroke Therapeutics Scope and Market Size
Acute Ischemic Stroke Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Thrombolytic Therapeutics
Antihypertensive Therapeutics
Antiplatelet Therapeutics
Anticoagulants

Segment by Application
Hospitals
Ambulatory Surgical Center
Diagnostic Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer
Boehringer Ingelheim
Roche
Sanofi
Biogen
Daiichi Sankyo
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Thrombolytic Therapeutics
1.2.3 Antihypertensive Therapeutics
1.2.4 Antiplatelet Therapeutics
1.2.5 Anticoagulants
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Therapeutics Market Perspective (2016-2027)
2.2 Acute Ischemic Stroke Therapeutics Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Ischemic Stroke Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Ischemic Stroke Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Ischemic Stroke Therapeutics Industry Dynamic
2.3.1 Acute Ischemic Stroke Therapeutics Market Trends
2.3.2 Acute Ischemic Stroke Therapeutics Market Drivers
2.3.3 Acute Ischemic Stroke Therapeutics Market Challenges
2.3.4 Acute Ischemic Stroke Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Ischemic Stroke Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Therapeutics Revenue
3.4 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Therapeutics Revenue in 2020
3.5 Acute Ischemic Stroke Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Therapeutics Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acute Ischemic Stroke Therapeutics Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Ischemic Stroke Therapeutics Market Size (2016-2027)
6.2 North America Acute Ischemic Stroke Therapeutics Market Size by Type
6.2.1 North America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Ischemic Stroke Therapeutics Market Size by Application
6.3.1 North America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Ischemic Stroke Therapeutics Market Size by Country
6.4.1 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Ischemic Stroke Therapeutics Market Size (2016-2027)
7.2 Europe Acute Ischemic Stroke Therapeutics Market Size by Type
7.2.1 Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Application
7.3.1 Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Ischemic Stroke Therapeutics Market Size by Country
7.4.1 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Ischemic Stroke Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Ischemic Stroke Therapeutics Market Size by Type
9.2.1 Latin America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Ischemic Stroke Therapeutics Market Size by Application
9.3.1 Latin America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country
9.4.1 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Acute Ischemic Stroke Therapeutics Introduction
11.1.4 Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Introduction
11.2.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Acute Ischemic Stroke Therapeutics Introduction
11.3.4 Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Acute Ischemic Stroke Therapeutics Introduction
11.4.4 Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Biogen
11.5.1 Biogen Company Details
11.5.2 Biogen Business Overview
11.5.3 Biogen Acute Ischemic Stroke Therapeutics Introduction
11.5.4 Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.5.5 Biogen Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Acute Ischemic Stroke Therapeutics Introduction
11.6.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.6.5 Daiichi Sankyo Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Acute Ischemic Stroke Therapeutics Introduction
11.7.4 Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021)
11.7.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Ischemic Stroke Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Thrombolytic Therapeutics
Table 3. Key Players of Antihypertensive Therapeutics
Table 4. Key Players of Antiplatelet Therapeutics
Table 5. Key Players of Anticoagulants
Table 6. Global Acute Ischemic Stroke Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Ischemic Stroke Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Ischemic Stroke Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2022-2027)
Table 12. Acute Ischemic Stroke Therapeutics Market Trends
Table 13. Acute Ischemic Stroke Therapeutics Market Drivers
Table 14. Acute Ischemic Stroke Therapeutics Market Challenges
Table 15. Acute Ischemic Stroke Therapeutics Market Restraints
Table 16. Global Acute Ischemic Stroke Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Ischemic Stroke Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2020)
Table 19. Ranking of Global Top Acute Ischemic Stroke Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Ischemic Stroke Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Ischemic Stroke Therapeutics Product Solution and Service
Table 23. Date of Enter into Acute Ischemic Stroke Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Ischemic Stroke Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Ischemic Stroke Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bayer Company Details
Table 64. Bayer Business Overview
Table 65. Bayer Acute Ischemic Stroke Therapeutics Product
Table 66. Bayer Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Bayer Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Acute Ischemic Stroke Therapeutics Product
Table 71. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Acute Ischemic Stroke Therapeutics Product
Table 76. Roche Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Sanofi Company Details
Table 79. Sanofi Business Overview
Table 80. Sanofi Acute Ischemic Stroke Therapeutics Product
Table 81. Sanofi Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Sanofi Recent Development
Table 83. Biogen Company Details
Table 84. Biogen Business Overview
Table 85. Biogen Acute Ischemic Stroke Therapeutics Product
Table 86. Biogen Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Biogen Recent Development
Table 88. Daiichi Sankyo Company Details
Table 89. Daiichi Sankyo Business Overview
Table 90. Daiichi Sankyo Acute Ischemic Stroke Therapeutics Product
Table 91. Daiichi Sankyo Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Daiichi Sankyo Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Acute Ischemic Stroke Therapeutics Product
Table 96. Pfizer Revenue in Acute Ischemic Stroke Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Ischemic Stroke Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Thrombolytic Therapeutics Features
Figure 3. Antihypertensive Therapeutics Features
Figure 4. Antiplatelet Therapeutics Features
Figure 5. Anticoagulants Features
Figure 6. Global Acute Ischemic Stroke Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Center Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Acute Ischemic Stroke Therapeutics Report Years Considered
Figure 11. Global Acute Ischemic Stroke Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Acute Ischemic Stroke Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Acute Ischemic Stroke Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Acute Ischemic Stroke Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Acute Ischemic Stroke Therapeutics Market Share by Players in 2020
Figure 16. Global Top Acute Ischemic Stroke Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Therapeutics Revenue in 2020
Figure 18. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Acute Ischemic Stroke Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Acute Ischemic Stroke Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Acute Ischemic Stroke Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Acute Ischemic Stroke Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Ischemic Stroke Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Acute Ischemic Stroke Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Acute Ischemic Stroke Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Acute Ischemic Stroke Therapeutics Market Share by Region (2016-2027)
Figure 40. China Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Ischemic Stroke Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Acute Ischemic Stroke Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Acute Ischemic Stroke Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Acute Ischemic Stroke Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Acute Ischemic Stroke Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 60. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 63. Biogen Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---